Rafferty Asset Management, LLC Mersana Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.16 - $5.94 $795,817 - $2.19 Million	368,434 New	368,434 $1.65 Million
Q2 2023 Aug 11, 2023	SELL	$3.08 - $9.55 $459,080 - $1.42 Million	-149,052 Reduced 30.69%	336,656 $1.11 Million
Q1 2023 May 11, 2023	BUY	$4.0 - $7.02 $275,376 - $483,284	68,844 Added 16.51%	485,708 $2 Million
Q4 2022 Feb 13, 2023	BUY	$5.65 - $7.86 $1.15 Million - $1.6 Million	203,101 Added 95.01%	416,864 $2.44 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $989,722 - $1.71 Million	213,763 New	213,763 $1.45 Million
Q1 2022 May 13, 2022	SELL	$3.74 - $6.63 $1.04 Million - $1.85 Million	-278,798 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.48 - $9.86 $639,855 - $1.15 Million	116,762 Added 72.06%	278,798 $1.73 Million
Q3 2021 Nov 10, 2021	BUY	$8.56 - $14.47 $381,416 - $644,754	44,558 Added 37.93%	162,036 $1.53 Million
Q2 2021 Aug 10, 2021	SELL	$13.28 - $18.07 $898,126 - $1.22 Million	-67,630 Reduced 36.54%	117,478 $1.6 Million
Q1 2021 May 10, 2021	BUY	$15.31 - $26.52 $2.36 Million - $4.08 Million	154,028 Added 495.59%	185,108 $3 Million
Q4 2020 Feb 10, 2021	SELL	$16.84 - $27.59 $780,786 - $1.28 Million	-46,365 Reduced 59.87%	31,080 $827,000
Q3 2020 Nov 13, 2020	BUY	$16.2 - $25.7 $1.07 Million - $1.69 Million	65,742 Added 561.75%	77,445 $1.44 Million
Q2 2020 Aug 07, 2020	BUY	$5.24 - $23.4 $61,323 - $273,850	11,703 New	11,703 $274,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.